Cargando…
Obesity induces limited changes to systemic and local immune profiles in treatment-naive human clear cell renal cell carcinoma
Understanding the effects of obesity on the immune profile of renal cell carcinoma (RCC) patients is critical, given the rising use of immunotherapies to treat advanced disease and recent reports of differential cancer immunotherapy outcomes with obesity. Here, we evaluated multiple immune parameter...
Autores principales: | Gibson, Justin T., Norris, Katlyn E., Wald, Gal, Buchta Rosean, Claire M., Thomas, Lewis J., Boi, Shannon K., Bertrand, Laura A., Bing, Megan, Gordetsky, Jennifer B., Deshane, Jessy, Li, Peng, Brown, James A., Nepple, Kenneth G., Norian, Lyse A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259552/ https://www.ncbi.nlm.nih.gov/pubmed/32469992 http://dx.doi.org/10.1371/journal.pone.0233795 |
Ejemplares similares
-
Obesity Triggers Enhanced MDSC Accumulation in Murine Renal Tumors via Elevated Local Production of CCL2
por: Hale, Malika, et al.
Publicado: (2015) -
Obesity diminishes response to PD-1-based immunotherapies in renal cancer
por: Boi, Shannon K, et al.
Publicado: (2020) -
Obesity Does Not Exacerbate the Protumorigenic Systemic Environment in Sarcoma Subjects
por: Buchta, Claire M., et al.
Publicado: (2017) -
Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice
por: Turbitt, William J., et al.
Publicado: (2021) -
The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer
por: Orlandella, Rachael M., et al.
Publicado: (2020)